Treatment of Premature Ejaculation with Unani Medicine Majoon-e-Piyaz

Clinical Validation of Unani Pharmacopoeal formulation Majoon-e-Piyaz in Surat Inzaal (Premature Ejaculation)

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/08/015405

Enrollment

240

Registered

2018-08-21

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N539- Unspecified male sexual dysfunction

Interventions

Intervention1: Majoon-e-Piyaz: Majoon-e-Piyaz Semi solid 7g Twice daily oral To be taken with water after meals for two weeks Control Intervention1: Nil: Nil

Eligibility

Inclusion criteria

Inclusion criteria: The following criteria will be strictly followed for inclusion of cases in the study. 1. Male patients in the age group of 21 to 65 years. 2. Men with an IELT ( Intra-vaginal ejaculatory latency time) of less than 1 minute will be included in the study 3. Men with a PEDT Score >11

Exclusion criteria

Exclusion criteria: The patients of Surat-e-Inzal (Premature ejaculation) with following conditions will be excluded from the study: 1. Patients with Erectile Dysfunction 2. Patients with diseases requiring long term treatment 3. Patients with cognitive impairments 4. History of addiction (smoking, alcohol, drugs)

Design outcomes

Primary

Measure	Time frame
Improvement in the sign and symptoms of NisyÄ?n (Amnesia)Timepoint: Two Weeks	—

Secondary

Measure	Time frame
Hematological and biochemical assessments for safetyTimepoint: 2 weeks	—

Countries

India

Contacts

Public ContactDr Pradeep Kumar

Central Council for Research in Unani Medicine (CCRUM)

ccrum507@rediffmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026